AI assistant
PMV Pharmaceuticals, Inc. — Director's Dealing 2025
Jul 3, 2025
34350_dirs_2025-07-03_8a8cf70e-9c0a-4f60-8525-3d4c7800ba02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2025-07-01
Reporting Person: Mack David Henry (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | Common Stock | S | 58411 | $1.0645 | Disposed | 536133 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 165307 | Indirect |
| Common Stock | 147915 | Indirect |
| Common Stock | 56978 | Indirect |
Footnotes
F1: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
F2: Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.
F3: The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4: The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F5: The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.